Pascal Urwyler

Kuster, S., Urwyler, P., Capoferri, G., Von Rotz, M., Ragozzino, S., Kuehl, R., Tesoro, C., Reuthebuch, O., Zenklusen, U., Scheifele, S., Eckstein, F., Keller, P. M., Schlaepfer, P., & Tschudin-Sutter, S. (2025). Aerosolization of Mycobacterium chelonae from heater-cooler-devices: a continuing risk of exposure during cardiac surgery. 14. https://doi.org/10.1186/s13756-025-01635-1

Urwyler, Pascal, Goldenberger, Daniel, Grosheintz, Kerstin, Tarnutzer, Rahel, Markstein, Maike, Sucker, Celine, Balestra, Anna-Maria, Merki, Lukas, Baumann, Michelle, Gürtler, Nicolas, Emmanuel Martinez, Aurélien, von Rotz, Matthias, Ivan, Branislav, Lang, Claudia, Schläepfer, Pascal, Keller, Peter M., Wuerfel, Eva, & Tschudin-Sutter, Sarah. (2025). Toxigenic Corynebacterium diphtheriae Infections in Low-Risk Patients, Switzerland, 2023. Emerging Infectious Diseases, 31(1), 164–167. https://doi.org/10.3201/eid3101.241138

Ragozzino, Silvio, Kuehl, Richard, Leuzinger, Karoline, Schläpfer, Pascal, Urwyler, Pascal, Durovic, Ana, Zingg, Sandra, von Rotz, Matthias, Battegay, Manuel, Widmer, Andreas F, Hirsch, Hans H, Bassetti, Stefano, & Tschudin-Sutter, Sarah. (2024). Secondary attack rate following on-site isolation of patients with suspected COVID-19 in multiple-bed rooms. Antimicrobial Resistance and Infection Control, 13. https://doi.org/10.1186/s13756-024-01430-4

Vock, Isabelle, Ragozzino, Silvio, Urwyler, Pascal, Baumann, Michelle, Capoferri, Gioele, Keller, Peter M., & Tschudin-Sutter, Sarah. (2024). Screening sites for detection of carbapenemase-producers– a retrospective cohort study. Antimicrobial Resistance and Infection Control, 13(1). https://doi.org/10.1186/s13756-024-01513-2

Brockhaus, Lisa, Urwyler, Pascal, Leutwyler, Ulrike, Würfel, Eva, Kohns Vasconcelos, Malte, Goldenberger, Daniel, Keller, Peter Michael, Tschudin Sutter, Sarah, & Labhardt, Niklaus Daniel. (2024). Diphtheria in a Swiss Asylum Seeker Reception Centre: Outbreak Investigation and Evaluation of Testing and Vaccination Strategies. International Journal of Public Health, 69. https://doi.org/10.3389/ijph.2024.1606791

Abu Hussein, Nebal S., Giezendanner, Stephanie, Urwyler, Pascal, Bridevaux, Pierre-Olivier, Chhajed, Prashant N., Geiser, Thomas, Joos Zellweger, Ladina, Kohler, Malcolm, Miedinger, David, Pasha, Zahra, Thurnheer, Robert, von Garnier, Christophe, & Leuppi, Joerg D. (2023). Risk Factors for Recurrent Exacerbations in the General-Practitioner-Based Swiss Chronic Obstructive Pulmonary Disease (COPD) Cohort [Journal-article]. Journal of Clinical Medicine, 12(20), 6695. https://doi.org/10.3390/jcm12206695

Capoferri, Gioele, Walti, Carla Simone, Urwyler, Pascal, Ragozzino, Silvio, Passweg, Jakob R., Halter, Jörg, Battegay, Manuel, Baettig, Veronika, Weisser, Maja, Arnold, Brice, Morin, Benedict, Guetlin, Yukino, Torres, Diana Albertos, Barut, Güliz Tuba, Thiel, Volker, Egli, Adrian, Drexler, Beatrice, & Khanna, Nina. (2023). Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 58(5), 597–599. https://doi.org/10.1038/s41409-023-01936-2

Urwyler, Pascal, Leimbacher, Marina, Charitos, Panteleimon, Moser, Stephan, Heijnen, Ingmar A. F. M., Trendelenburg, Marten, Thoma, Reto, Sumer, Johannes, Camacho-Ortiz, Adrián, Bacci, Marcelo R., Huber, Lars C., Stüssi-Helbling, Melina, Albrich, Werner C., Sendi, Parham, & Osthoff, Michael. (2023). Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1255292

Urwyler, Pascal, Moser, Stephan, Trendelenburg, Marten, Sendi, Parham, & Osthoff, Michael. (2022). Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression. Molecular Immunology, 150, 99–113. https://doi.org/10.1016/j.molimm.2022.08.008

Urwyler, Pascal, Charitos, Panteleimon, Moser, Stephan, Heijnen, Ingmar A. F. M., Trendelenburg, Marten, Thoma, Reto, Sumer, Johannes, Camacho-Ortiz, Adrián, Bacci, Marcelo R., Huber, Lars C., Stüssi-Helbling, Melina, Albrich, Werner C., Sendi, Parham, & Osthoff, Michael. (2021). Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Trials, 22(1). https://doi.org/10.1186/s13063-020-04976-x

Urwyler, Pascal, Moser, Stephan, Charitos, Panteleimon, Heijnen, Ingmar A. F. M., Rudin, Melanie, Sommer, Gregor, Giannetti, Bruno M., Bassetti, Stefano, Sendi, Parham, Trendelenburg, Marten, & Osthoff, Michael. (2020). Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.02072

Urwyler, P., Earnshaw, I., Bermudez, M., Perucha, E., Wu, W., Ryan, S., Mcdonald, L., Karagiannis, S.N., Taams, L.S., Powell, N., Cope, A., & Papa, S. (2020). Mechanisms of checkpoint inhibition-induced adverse events. Clinical and Experimental Immunology, 200(2), 141–154. https://doi.org/10.1111/cei.13421

Urwyler, Pascal, Boesing, Maria, Abig, Kristin, Cattaneo, Marco, Dieterle, Thomas, Zeller, Andreas, Bachler, Herbert, Markun, Stefan, Senn, Oliver, Merlo, Christoph, Essig, Stefan, Ullmer, Elke, Rutishauser, Jonas, Schuurmans, Macé M, & Leuppi, Joerg Daniel. (2019). Reduction of corticosteroid use in outpatient treatment of exacerbated COPD-Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial). Trials, 20(1). https://doi.org/10.1186/s13063-019-3856-8

Urwyler, Pascal, Abu Hussein, Nebal, Bridevaux, Pierre O., Chhajed, Prashant N., Geiser, Thomas, Grendelmeier, Peter, Joos Zellweger, Ladina, Kohler, Malcolm, Maier, Sabrina, Miedinger, David, Tamm, Michael, Thurnheer, Robert, Dieterle, Thomas, & Leuppi, Joerg D. (2019). Predictive factors for exacerbation and re-exacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort. Multidisciplinary Respiratory Medicine, 14(7), 7. https://doi.org/10.1186/s40248-019-0168-5

Carron, Tania, Bridevaux, Pierre-Olivier, Lörvall, Karin, Parmentier, Rachel, Moix, Jean-Bernard, Beytrison, Vincent, Pernet, Raymond, Rey, Constance, Roberfroid, Pierre-Yves, Chhajed, Prashant N., Dieterle, Thomas, Joos Zellweger, Ladina, Kohler, Malcolm, Maier, Sabrina, Miedinger, David, Thurnheer, Robert, Urwyler, Pascal, Tschopp, Jean-Marie, Zuercher, Emilie, et al. (2017). Feasibility, acceptability and effectiveness of integrated care for COPD patients: a mixed methods evaluation of a pilot community-based programme. Swiss Medical Weekly, 147, w14567. https://doi.org/10.4414/smw.2017.14567

Urwyler P, & Heininger U. (2014). Protecting newborns from pertussis - the challenge of complete cocooning. BMC Infectious Diseases, 14(1), 397. https://doi.org/10.1186/1471-2334-14-397

Urwyler P, Dierig A, Walther K, & Heininger U. (2014). Protection against vaccine-preventable diseases in medical students: A follow up. Pediatric Infectious Disease Journal, 33(10), 1057–1059. https://doi.org/10.1097/inf.0000000000000381